Subscribe To
Moderna (mrna) to report q1 earnings: will it beat estimates?
Investors focus will likely be on Moderna's (MRNA) pipeline, especially its late-stage pipeline candida...
April 28, 2023, 9:52 am
Hillstream biopharma announces pricing of public offering
BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnol...
April 28, 2023, 1:50 am
: republican megadonor peter thiel won’t fund any candidates in 2024: reports
Tech billionaire and major Republican donor Peter Thiel does not plan on funding any political candidat...
April 27, 2023, 1:25 am
7 of the best penny stocks under $3 to buy right now
When it comes to finding the best penny stocks under $3 to buy now, there are scores of potential candid...
April 26, 2023, 9:06 pm
Evelo biosciences provides clinical updates
– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on developme...
April 26, 2023, 11:30 am
Uvax bio announces publication of results from preclinical studies of hiv vaccine candidates
Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategies Phase 1 clinical trial sponso...
April 26, 2023, 11:30 am
Mindset pharma files two international patent applications under the patent cooperation treaty
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it has filed two international patent applications under the Patent Cooperation Treaty (PCT) to prote...
April 26, 2023, 8:20 am
Morphic: positive phase 2a uc trial, top m&a candidate in 2023
Morphic: Positive Phase 2a UC Trial, Top M&A candidate In 2023....
April 25, 2023, 10:20 pm
Virios therapeutics stock doubles as fibromyalgia program moves forward
Virios Therapeutics shares more than doubled after the biotechnology company announced that its proposed Phase 3 program featuring its lead developmen...
April 25, 2023, 10:48 am
Why is virios therapeutics (viri) stock up 92% today?
Virios Therapeutics (NASDAQ: VIRI ) stock is rocketing higher on Tuesday following an update on its planned Phase 3 clinical trial of IMC-1. IMC-1 is...
April 25, 2023, 8:01 am
Dermata (drma) gains on positive fda response for acne candidate
Dermata (DRMA) gains on positive FDA response for the further development of DMT310 for treating severe to moderate acne....
April 21, 2023, 1:43 pm
Why prometheus biosciences stock is skyrocketing this week
Merck plans to acquire Prometheus for $10.8 billion in an all-cash deal. The deal will add Prometheus' lead ca...
April 20, 2023, 4:24 pm
Disney tells its lobbyists to step up fight against florida gov. ron desantis
CNBC's Brian Schwartz joins 'The Exchange' to discuss Disney increasing its lobbying effort against Ron DeSantis, the GOP moving away from Ron DeSanti...
April 20, 2023, 2:56 pm
Disney goes to war with desantis as lobbyists told to gird for florida battle: report
DeSantis, a likely GOP presidential candidate who has attacked "woke Disney," said the company has long...
April 20, 2023, 2:20 pm
Why madrigal pharmaceuticals stock gained 20% this week
On Tuesday, Madrigal won an important regulatory designation from the FDA for its NASH candidate. The b...
April 20, 2023, 2:06 pm
Vyne gains on preclinical data for ipf candidate
VYNE gains on positive preclinical data evaluating VYN201 for treating idiopathic pulmonary fibrosis....
April 20, 2023, 12:57 pm
Biovie's degenerative dementia drug candidate to be presented at psychiatry conference
BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its Phase 2 open-label trial of its degenerative dementia drug ...
April 20, 2023, 10:24 am
Recruiter.com launches artificial intelligence powered candidate pitch web app
Recruiter.com Group, Inc. (NASDAQ:RCRT), which helps to streamline the hiring process for employers and job seekers alike, revealed that it has beta l...
April 20, 2023, 10:12 am
Cognition therapeutics to present analysis showing impact of ct1812 on pathways implicated in dry age-related macular degeneration at arvo 2023
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be presenting in vitro results characterizing the role ...
April 19, 2023, 11:30 am
Could this rare-disease drug candidate become a blockbuster?
AstraZeneca and Ionis recently shared promising phase 3 clinical trials for eplontersen. If approved, the drug ...
April 19, 2023, 9:15 am